Oncologic safety of sentinel lymph node biopsy using blue dye after neoadjuvant chemotherapy for breast cancer

Contribution: Clinical data acquisition, eligibility assessment, data extraction, cleaning, and harmonization.

Resources: Paper Link | DOI: 10.1111/1744-1633.70065